Table 2.
Laboratory variables | Number of observations | Odds ratio (95% CI) | p-value | AIC | BIC |
---|---|---|---|---|---|
NLR | 1451 | 1.459 (1.028–2.069) | 0.034 | 955.419 | 1002.940 |
PLR | 990 | 4.842 (2.029–11.549) | <0.001 | 526.977 | 571.057 |
ESR | 669 | 4.397 (2.128–9.085) | <0.001 | 365.383 | 405.935 |
CRP | 904 | 2.911 (1.518–5.584) | 0.001 | 566.035 | 609.296 |
PLR (+ ESR) | 560 | 8.200 (1.352–49.731) | 0.022 | 272.468 | 315.748 |
PLR (+ CRP) | 549 | 18.361 (3.230–104.379) | 0.001 | 286.151 | 329.323 |
All models controlled for gender, age, duration of disease, tobacco use, education, marital status, working status. The final models (+ ESR and + CRP) tested for associations of PLR and sacroiliitis after inclusion either ESR or CRP in the model.
NLR was not significant (P>0.05) for any model that included ESR and CRP (data not shown).
mNY, modified New York; NLR, neutrophil-lymphocyte ratio; PLR, platelet-lymphocyte ratio; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; CI, confidence interval; AIC, Akaike Information Criteria; BIC, Bayesian Information Criteria; mm/Hr, millimeters per hour; mg/dL, milligrams per deciliter